Authors


Anne Aunins

Latest:

Integrating CMC Document Preparation into the Development Process for Vaccine INDs

Vaccine process development is complex, and so are the documents required before clinical trials begin. Technical writers and editors can effectively coordinate the timely authoring, reviewing, and auditing of regulatory documents, minimizing filing delays.


Thomas P. Loisel

Latest:

Solutions for Purification of Fc-fusion Proteins

When platform processes are applied to fusion molecules, innovation and flexibility are needed.





Paul Johnson

Latest:

The Development and Application of a Monoclonal Antibody Purification Platform

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.


Thomas Mueller-Spaeth, PhD

Latest:

Increasing Capacity Utilization in Protein A Chromatography

A twin-column periodic countercurrent capture process that combines an efficient sequential, countercurrent loading process with a minimal twin-column hardware configuration is described.



Benedicte Lebreton

Latest:

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.


Suma Ray, PhD

Latest:

Key Considerations for Development and Production of Vaccine Products

Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.



Satyam S. Nampalli

Latest:

Strategies for Sourcing Animal-Origin Free Cell Culture Media Components

How to successfully balance patient safety with supply-chain management


Gill A. Webster, PhD

Latest:

The Therapeutic Vaccine Potential of MIS416 Adjuvant

This article discusses the potential of MIS416 adjuvant, a vaccine adjuvant and immunogen co-delivery system, to provide adequate immunostimulation to overcome host factors that may limit the success of therapeutic vaccines.


Wang-Ting Hsieh, PhD

Latest:

Detection of Cache Valley Virus in Biologics Manufactured in CHO Cells

Avoid manufacturing failures by effective viral inactivation.


Archie Lovatt, PhD

Latest:

Detection of Cache Valley Virus in Biologics Manufactured in CHO Cells

Avoid manufacturing failures by effective viral inactivation.


Andre Collioud

Latest:

Developing and Manufacturing Attenuated Live Bacterial Vaccines

There are a number of specific characteristics to be considered when developing and manufacturing live bacterial vaccines.


Julie Paul

Latest:

Validation Outsourcing: Getting the Most Out of Your Client?Contractor Relationship

Supplementing your existing staff with experienced contractors when your process is ready for validation can help you avoid common validation mishaps - if you know the ingredients of successful project management.


David W. Husman, PhD

Latest:

Pharmaceutical Quality Success: It's All About Management

Engaging executive leadership in the quality process is the key to compliance success.


Amber R. Cothran

Latest:

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.


Terry Burns

Latest:

Disposable Bioreactors for Cells and Microbes

Productivities similar to those achieved with stirred tanks can be achieved with disposable bioreactors.


Carlos Escobar

Latest:

Chromatography Optimization Strategy

Robust packing procedures can improve process performance and increase resin lifetime.



Radu Georgescu

Latest:

Leveraging Fermentation Heat Transfer Data to Better Understand Metabolic Activity

A simple method to leverage fermentation heat transfer data.


Niall Dinwoodie

Latest:

Biobetters and the Future Biologics Market

Despite their difficult approval pathway, biobetters offer the potential for innovation and decreased healthcare costs.



Sandra K. Dusing, PhD

Latest:

Detection of Cache Valley Virus in Biologics Manufactured in CHO Cells

Avoid manufacturing failures by effective viral inactivation.


Beth H. Junker

Latest:

Building a Business Case for Biopharmaceutical QbD Implementation (Peer Reviewed)

The author describes a methodology for developing a per product qualitative and semi-qualitative business case for applying QbD to a biopharmaceutical product.




Gisela Ferreira, PhD

Latest:

Advances in Non-Protein A Purification Processes for Human Monoclonal Antibodies

In three non-affinity purification processes based on cation exchange capture with high binding capacity, applying a host cell protein exclusion strategy enabled robust scale up and better economics.

© 2025 MJH Life Sciences

All rights reserved.